The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
Open accessAbstract
In atherosclerosis and Alzheimer's disease, deposition of the altered self components oxidized low-density lipoprotein (LDL) and amyloid-beta triggers a protracted sterile inflammatory response. Although chronic stimulation of the innate immune system is believed to underlie the pathology of these diseases, the molecular mechanisms of activation remain unclear. Here we show that oxidized LDL and amyloid-beta trigger inflammatory signaling through a heterodimer of Toll-like receptors 4 and 6. Assembly of this newly identified heterodimer is regulated by signals from the scavenger receptor CD36, a common receptor for these disparate ligands. Our results identify CD36-TLR4-TLR6 activation as a common molecular mechanism by which atherogenic lipids and amyloid-beta stimulate sterile inflammation and suggest a new model of TLR heterodimerization triggered by coreceptor signaling events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Stewart and colleagues demonstrated that Aβ-mediated release of proinflammatory factors and neurotoxicity partially involved signaling through the CD36/ TLR4/TRL6 complex (108).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [108]
In the citing paper
“CD36 mediates heterodimer formation of TLR4 and TLR6 (REF. 104), and this co-receptor complex upregulates the production of chemokines and cytokines such as pro-IL-1β through the activation of NF-κb.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [105]
In the citing paper
“The Soluble Aβ oligomers and Aβ fibrils can react to various receptors expressed by microglia, including CD14, CD36, CD47, α6β1 integrin, class A scavenger receptor, receptor for advanced glycosylation end products (RAGE) and TLRs (Stewart et al., 2010).”
From The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma. (2017) · cites this paper as Stewart et al., 2010
In the citing paper
“The binding of Aβ to CD36 (cell surface microglial co-receptor) promotes the TLR4 and/or TLR6 phosphorylation and activation, resulting in the production of inflammatory cytokines and chemokines (Stewart et al., 2010).”
From The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma. (2017) · cites this paper as Stewart et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Recognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
Self-citationOzinsky, A., Underhill, D. M., Fontenot, J. D., Hajjar, A. M., Smith, K. D., Wilson, C. B., Schroeder, L. A., & Aderem, A. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250476497 · Cited by 2,086
Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2
Gantner, B. N., Simmons, R. M., Canavera, S. J., Akira, S., & Underhill, D. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021787 · Cited by 1,682
TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β
Kagan, J. C., Su, T., Horng, T., Chow, A. Y., Akira, S., & Medzhitov, R. M. (2008) · Nature Immunology · doi:10.1038/ni1569 · Cited by 1,310
Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284
Immortalization of murine microglial cells by a v-raf / v-myc carrying retrovirus
Blasi, E., Barluzzi, R., Bocchini, V., Mazzolla, R., & Bistoni, F. (1990) · Journal of Neuroimmunology · doi:10.1016/0165-5728(90)90073-v · Cited by 1,076
Kunjathoor, V., Febbraio, M., Podrez, E., Moore, K., Andersson, L., Koehn, S. L., Rhee, J. S., Silverstein, R., Hoff, H., & Freeman, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209649200 · Cited by 1,064
Self-citation
Cited by
Sorted by citations
Items 801–900 of 1,001
Deciphering Macrophage Phenotypes upon Lipid Uptake and Atherosclerosis
Lee, J., & Choi, J. (2020) · Immune Network · doi:10.4110/in.2020.20.e22 · Cited by 30
Autophagy & Phagocytosis in Neurological Disorders and their Possible Cross-talk
Li, G., Sherchan, P., Tang, Z., & Tang, J. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210407150632 · Cited by 29
Cholesterol-Induced M4-Like Macrophages Recruit Neutrophils and Induce NETosis
Maretti-Mira, A. C., Golden‐Mason, L., Salomon, M. P., Kaplan, M. J., & Rosen, H. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.671073 · Cited by 29
Kim, I., Ju, H., Minkler, J., Jiang, R. R., Singh, A. S. C., Sharma, R., Febbraio, M., & Cho, S. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231154602 · Cited by 30
Mendel, I., Feige, E., Yacov, N., Salem, Y., Levi, I., Propheta‐Meiran, O., Shoham, A., Ishai, E., George, J., Harats, D., et al. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12212 · Cited by 29
Regulation of IL-17 in atherosclerosis and related autoimmunity
Ryu, H., & Chung, Y. (2015) · Cytokine · doi:10.1016/j.cyto.2015.03.009 · Cited by 29
Kakoty, V., Sarathlal, K. C., Kumari, S., Yang, C., Dubey, S. K., Sahebkar, A., Kesharwani, P., & Taliyan, R. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01187-z · Cited by 30
Liu, S., Chen, L., Li, J., Sun, Y., Xu, Y., Li, Z., Zhu, Z., & Li, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511976 · Cited by 28
Balan, I. S., Warnock, K. T., Puché, A. C., Gondré‐Lewis, M. C., June, H. L., & Aurelian, L. (2018) · Brain Sciences · doi:10.3390/brainsci8040072 · Cited by 28
Jerez, D., Torramadé‐Moix, S., Palomo, M., Moreno‐Castaño, A. B., López-Vílchez, I., Hernandez, R., Badimón, J. J., Zafar, M. U., Díaz‐Ricart, M., & Escolar, G. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.12.017 · Cited by 28
Martínez-García, M. Á., Ojeda, M. O., Rodríguez‐Martín, E., Insenser, M. R., Moncayo, S., Álvarez‐Blasco, F., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2020) · Biomolecules · doi:10.3390/biom10010111 · Cited by 33
Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis
Hoebinger, C., Rajcic, D., & Hendrikx, T. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.824481 · Cited by 32
Gut microbiota, pathogenic proteins and neurodegenerative diseases
Wei, W., Wang, S., Xu, C., Zhou, X., Lian, X., He, L., & Li, K. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.959856 · Cited by 30
HIV-1 Nef Impairs Key Functional Activities in Human Macrophages through CD36 Downregulation
Olivetta, E., Tirelli, V., Chiozzini, C., Scazzocchio, B., Romano, I., Arenaccio, C., & Sanchez, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093699 · Cited by 30
Friedli, O., & Freigang, S. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.07.006 · Cited by 28
Café-Mendes, C. C., Garay-Malpartida, M., Malta, M. B., Lima, L. D. S., Scavone, C., Ferreira, Z. S., Markus, R. P., & Marcourakis, T. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.10.056 · Cited by 30
The Microglial Response to Neurodegenerative Disease
Song, W. M., & Colonna, M. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.04.002 · Cited by 30
CD 36: Focus on Epigenetic and Post-Transcriptional Regulation
Niculite, C. M., Enciu, A., & Hinescu, M. E. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00680 · Cited by 28
Jiang, M., Incarnato, D., Modderman, R., Lazaro, A. A., Jonkers, I. H., Bianchi, F., & van den Bogaart, G. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.109962 · Cited by 28
Association of Toll-like receptor polymorphisms with HIV status in North Americans
Willie, B., Hall, N. B., Stein, C. M., Jurevic, R. J., Weinberg, A., Mehlotra, R. K., & Zimmerman, P. A. (2014) · Genes and Immunity · doi:10.1038/gene.2014.54 · Cited by 27
Vav Guanine Nucleotide Exchange Factors Regulate Atherosclerotic Lesion Development in Mice
Rahaman, S. O., Li, W., & Silverstein, R. L. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301414 · Cited by 27
Physiological and pathogenic role of scavenger receptors in humans
Gusev, E., Zotova, N. V., Zhuravleva, Y. A., & Черешнев, В. А. (2020) · Medical Immunology (Russia) · doi:10.15789/1563-0625-pap-1893 · Cited by 28
Yabuta, S., & Shidoji, Y. (2020) · Bioscience Reports · doi:10.1042/bsr20194118 · Cited by 29
The Molecular Pathways of Pyroptosis in Atherosclerosis
Song, D., Li, M., Yu, X., Wang, Y., Fan, J., Yang, W. P., Yang, L. M., & Li, H. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.824165 · Cited by 27
Microglial activation in Alzheimer's disease: The role of flavonoids and microRNAs
Medrano-Jiménez, E., Meza‐Sosa, K. F., Aragon, J. A. U., Secundino, I., Pedraza-Alva, G., & Pérez-Martínez, L. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr1021-531r · Cited by 28
Landscape of immune infiltration in entorhinal cortex of patients with Alzheimerʼs disease
Zhang, H., Cao, S., Xu, Y., Sun, X., Fei, M., Jing, Q., Xu, X., Tang, J., Niu, B., & Li, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.941656 · Cited by 27
Ting, K. K. Y., Yu, P., Dow, R., Floro, E. J., Ibrahim, H. M., Scipione, C. A., Hyduk, S. J., Polenz, C. K., Zaslaver, O., Karmaus, P. W. F., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300293 · Cited by 27
Bzowska, M., Nogieć, A., Skrzeczyńska-Moncznik, J., Mickowska, B., Guzik, K., & Pryjma, J. R. (2012) · Inflammation · doi:10.1007/s10753-012-9472-3 · Cited by 27
Bennett, N. K., Chmielowski, R., Abdelhamid, D. S., Faig, J. J., Francis, N. L., Baum, J., Pang, Z. P., Uhrich, K. E., & Moghe, P. V. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.001 · Cited by 27
Borzęcka-Solarz, K., Dembinńska, J., Hromada‐Judycka, A., Traczyk, G., Ciesielska, A., Ziemlińska, E., Świątkowska, A., & Kwiatkowska, K. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-09-0632 · Cited by 27
Wei, X., Zhao, T., Ai, K., Li, H., Jiang, X., Cheng, L., Wang, Q., Yang, J., Zhang, R., & Yang, J. (2018) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2018.01.023 · Cited by 27
Nijat, D., Zhao, Q., Abdurixit, G., Jianhua, H., Liu, H., & Li, J. (2025) · Phytotherapy Research · doi:10.1002/ptr.70037 · Cited by 27
Zheng, M., Jones, D. M., Horzempa, C., Prasad, A., & McKeown‐Longo, P. J. (2011) · Journal of Cancer · doi:10.7150/jca.2.478 · Cited by 26
PKCδ-IRAK1 axis regulates oxidized LDL-induced IL-1β production in monocytes
Tiwari, R. L., Singh, V., Singh, A., Rana, M., Verma, A. R., Kothari, N., Kohli, M., Bogra, J., Dikshit, M., & Barthwal, M. K. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m045658 · Cited by 26
Amyloid Beta Hypothesis in Alzheimer's Disease: Major Culprits and Recent Therapeutic Strategies
Dileep, K. V., & Chandra, R. (2019) · Current Drug Targets · doi:10.2174/1389450120666190806153206 · Cited by 26
Sanjay, S., Park, M., & Lee, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137300 · Cited by 28
Role of microbial dysbiosis in the pathogenesis of Alzheimer's disease
Susmitha, G., & Kumar, R. K. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109478 · Cited by 27
Onofrio, L. I., Arocena, A. R., Paroli, A. F., Cabalén, M. E., Andrada, M. C., Cano, R. C., & Gea, S. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003464 · Cited by 27
Environment-mediated drug resistance in Bcr/Abl-positive acute lymphoblastic leukemia
Feldhahn, N., Arutyunyan, A., Stoddart, S., Zhang, B., Schmidhuber, S. M., Yi, S.-J., Kim, Y., Groffen, J., & Heisterkamp, N. (2012) · OncoImmunology · doi:10.4161/onci.20249 · Cited by 26
Innate immune recognition receptors and damage-associated molecular patterns in plaque inflammation
Lundberg, A. M., & Yan, Z.-Q. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834ada80 · Cited by 26
Lu, Z., Li, Y., Brinson, C. W., Kirkwood, K. L., Lopes-Virella, M. F., & Huang, Y. Q. (2016) · Oral Diseases · doi:10.1111/odi.12596 · Cited by 27
Wu, Y.-M., Yang, L., Li, X., Li, L., Wang, Q., & Li, W. (2017) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2017.09.034 · Cited by 28
Methionine oxidized apolipoprotein A‐I at the crossroads of HDL biogenesis and amyloid formation
Witkowski, A., Chan, G. K. L., Boatz, J. C., Li, N. J., Inoue, A. P., Wong, J. C., van der Wel, P. C. A., & Cavigiolio, G. (2018) · The FASEB Journal · doi:10.1096/fj.201701127r · Cited by 26
Diaz, L., & Bielczyk-Maczyńska, E. (2025) · Open Biology · doi:10.1098/rsob.240372 · Cited by 27
Alemán-Villa, K. M., Armienta-Rojas, D. A., Camberos-Barraza, J., Rábago-Monzón, Á. R., Camacho-Zamora, A., Osuna‐Ramos, J. F., Magaña‐Gómez, J. A., Guadrón‐Llanos, A. M., Calderón-Zamora, L., Norzagaray-Valenzuela, C. D., et al. (2025) · NeuroImmunoModulation · doi:10.1159/000548021 · Cited by 34
Is Targeting the Inflammasome a Way Forward for Neuroscience Drug Discovery?
Swanton, T., Cook, J., Beswick, J. A., Freeman, S., Lawrence, C. B., & Brough, D. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218786210 · Cited by 26
Scavenger Receptors: Novel Roles in the Pathogenesis of Liver Inflammation and Cancer
Patten, D. A., Wilkinson, A. L., O'Keeffe, A., & Shetty, S. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1733876 · Cited by 26
Dorighello, G. G., Assis, L. H. P., Rentz, T., Morari, J., Santana, M. D. F. M., Passarelli, M., Ridgway, N. D., Vercesi, A. E., & Oliveira, H. C. F. (2022) · Antioxidants · doi:10.3390/antiox11091734 · Cited by 25
Jang, J., Jo, Y., & Park, C. B. (2022) · ACS Nano · doi:10.1021/acsnano.2c06759 · Cited by 25
Hamann, L., Koch, A. H., Sur, S., Hoefer, N., Glaeser, C., Schulz, S., Gross, M. C., Franke, A., Nöthlings, U., Zacharowski, K. D., et al. (2013) · Immunity & Ageing · doi:10.1186/1742-4933-10-43 · Cited by 37
Inflammation in Atherosclerosis
Lauterbach, M., Labzin, L. I., & Latz, E. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch49 · Cited by 26
Monocyte and macrophage foam cells in diabetes-accelerated atherosclerosis
Cervantes, J., & Kanter, J. E. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1213177 · Cited by 24
Innate Immune Pathways in Atherosclerosis—From Signaling to Long-Term Epigenetic Reprogramming
Aronova, A., Tosato, F., Naser, N., & Asare, Y. (2023) · Cells · doi:10.3390/cells12192359 · Cited by 24
Mouse models of atherosclerosis: explaining critical roles of lipid metabolism and inflammation
Mukhopadhyay, R. (2013) · Journal of Applied Genetics · doi:10.1007/s13353-013-0134-4 · Cited by 24
Li, Y., Wang, Y., Chen, Y., Wang, Y., Zhang, S., Liu, P., Chen, Z., Song, P., Luo, L., Luo, Y., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01611 · Cited by 24
CD36 deficiency ameliorates drug-induced acute liver injury in mice
Zhang, C., Shi, X., Su, Z., Hu, C., Mu, X., Pan, J., Li, M., Teng, F., Tao, L., Zhao, T., et al. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00325-z · Cited by 24
Louie, A. Y., Tingling, J. D., Dray, E. L., Hussain, J., McKim, D. B., Swanson, K. S., & Steelman, A. J. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100927 · Cited by 24
Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer’s Disease?
Lue, L., Andrade, C., Sabbagh, M. N., & Walker, D. G. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/918680 · Cited by 24
CD36 Recruits α5β1 Integrin to Promote Cytoadherence of P. falciparum-Infected Erythrocytes
Davis, S. P., Lee, K., Gillrie, M. R., Roa, L., Amrein, M., & Ho, M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003590 · Cited by 24
Wei, X., Sun, G., Zhao, X., Wu, Q., Chen, L., Xu, Y., Pang, X., & Qi, G. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4286 · Cited by 24
Tang, M., Li, X., Yang, L., Wang, Q., & Li, W. (2019) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2019.103496 · Cited by 26
Specialised lipid mediators and their targets
Crean, D., & Godson, C. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.05.002 · Cited by 25
Major, A. S., & Harrison, D. G. (2011) · Circulation · doi:10.1161/circulationaha.111.070565 · Cited by 24
CHARMM GUI Membrane Builder for oxidized phospholipid membrane modeling and simulation
Brown, T. P., Santa, D. E., Berger, B. A., Kong, L., Wittenberg, N. J., & Im, W. (2024) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2024.102813 · Cited by 23
Ketotherapeutics for neurodegenerative diseases
Norwitz, N. G., Gilbert‐Jaramillo, J., Clarke, K., & Soto-Mota, A. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.02.003 · Cited by 24
Endothelial Cell CD36 Reduces Atherosclerosis and Controls Systemic Metabolism
Rekhi, U., Omar, M. A., Alexiou, M. V., Delyea, C., Immaraj, L., Elahi, S., & Febbraio, M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.768481 · Cited by 27
Francelle, L., & Mazzulli, J. R. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147798 · Cited by 23
Zhang, R., Zhou, T., Samanta, S., Luo, Z., Li, S., Xu, H., & Qu, J. (2022) · Frontiers in Neuroimaging · doi:10.3389/fnimg.2022.903531 · Cited by 24
Biological and therapeutic role of LSD1 in Alzheimer’s diseases
Li, Y., Zhao, Y., Li, X., Zhai, L., Zheng, H., Yan, Y., Fu, Q., Ma, J., Fu, H., Zhang, Z., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1020556 · Cited by 25
Waigi, E. W., Webb, R. C., Moss, M. A., Uline, M. J., McCarthy, C. G., & Wenceslau, C. F. (2023) · GeroScience · doi:10.1007/s11357-023-00748-y · Cited by 26
Croquemort elicits activation of the immune deficiency pathway in ticks
O’Neal, A. J., Singh, N., Rolandelli, A., Laukaitis-Yousey, H. J., Wang, X., Shaw, D. K., Young, B. D., Narasimhan, S., Dutta, S., Snyder, G. A., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2208673120 · Cited by 23
Advances of Genome Editing with CRISPR/Cas9 in Neurodegeneration: The Right Path towards Therapy
Klinkovskij, A., Shepelev, M. V., Isaakyan, Y. A., Aniskin, D., & Ulasov, I. V. (2023) · Biomedicines · doi:10.3390/biomedicines11123333 · Cited by 24
Zhang, D.-D., Yan, H., Hu, Y., Zhuang, Z., Zhuang, Y., & Hang, C. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2014.12.019 · Cited by 23
Yang, N., Zhang, D., Tao, Z., Li, M., Zhou, S., & Wang, G. (2016) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2016.09.023 · Cited by 23
The Toll Pathway in the Central Nervous System of Flies and Mammals
Shmueli, A., Shalit, T., Okun, E., & Shohat-Ophir, G. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8515-9 · Cited by 23
Neurodegenerative disorders and sterile inflammation: lessons from a Drosophila model
Nainu, F., Salim, E., Asri, R. M., Hori, A., & Kuraishi, T. (2019) · The Journal of Biochemistry · doi:10.1093/jb/mvz053 · Cited by 24
Scavenger receptor B8 improves survivability by mediating innate immunity in silkworm, Bombyx mori
Zhang, K., Hu, X., Zhao, Y., Pan, G., Li, C., Ji, H., Li, C., Yang, L., Abbas, M. N., & Cui, H. (2020) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2020.103917 · Cited by 23
Lee, J., Wang, P., Yang, I.-H., Wu, C., & Chuang, J. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.03.002 · Cited by 23
Protein engineering methods applied to membrane protein targets
Lluis, M., Godfroy, J. I., & Yin, H. H. (2012) · Protein Engineering Design and Selection · doi:10.1093/protein/gzs079 · Cited by 23
Shikama, Y., Kudo, Y., Ishimaru, N., & Funaki, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040836 · Cited by 25
Toll-Like Receptors and Src-Family Kinases in Atherosclerosis – Focus on Macrophages –
Wang, J., & Aikawa, M. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-1039 · Cited by 23
Amo-Aparicio, J., Dinarello, C. A., & Lopez-Vales, R. (2024) · Neural Regeneration Research · doi:10.4103/1673-5374.391330 · Cited by 25
The Pathogenic Role of the Adaptive Immune Response to Modified LDL in Diabetes
Virella, G., & Lopes-Virella, M. F. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00076 · Cited by 22
Witkowski, A., Carta, S., Lu, R., Yokoyama, S., Rubartelli, A., & Cavigiolio, G. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005663 · Cited by 22
The atherogenic role of immune cells in familial hypercholesterolemia
Taghizadeh, E., Taheri, F., Hayat, S. M. G., Montecucco, F., Carbone, F., Rostami, D., Montazeri, A., & Sahebkar, A. (2019) · IUBMB Life · doi:10.1002/iub.2179 · Cited by 22
Wang, Y., Fang, C., Xu, L., Yang, B. V., Song, E., & Song, Y. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.1c00214 · Cited by 22
Malter, J. S. (2022) · Translational research · doi:10.1016/j.trsl.2022.09.003 · Cited by 23
Lipid Regulators during Atherogenesis: Expression of LXR, PPAR, and SREBP mRNA in the Human Aorta
Shchelkunova, T. A., Morozov, I. A., Рубцов, П. М., Bobryshev, Y. V., Sobenin, I. A., Orekhov, A. N., Andrianova, I. V., & Smirnov, A. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063374 · Cited by 22
Cholesterol, Inflammasomes, and Atherogenesis
Ordovás, J. M., & Ordovás-Montañés, J. (2011) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-011-0212-2 · Cited by 22
The dynamic lives of macrophage and dendritic cell subsets in atherosclerosis
Taghavie-Moghadam, P. L., Butcher, M. J., & Galkina, E. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12392 · Cited by 21
Liu, H., Xu, W., Yu, Q., & Yang, Q. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00483 · Cited by 22
Beccaria, C., Silvestrini, P., Renna, M. S., Ortega, H. H., Calvinho, L. F., Dallard, B. E., & Baravalle, C. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.06.010 · Cited by 22
Rollercoaster ride of kynurenines: steering the wheel towards neuroprotection in Alzheimer’s disease
Sharma, R., Razdan, K., Bansal, Y., & Kuhad, A. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1524877 · Cited by 22
Faraj, M. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.34.20190124 · Cited by 23
Jordö, E. D., Wermeling, F., Chen, Y., & Karlsson, M. C. I. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.01.010 · Cited by 22
Lipolysis engages CD36 to promote ZBP1-mediated necroptosis-impairing lung regeneration in COPD
Wang, J., Wang, R., Li, Y., Huang, J.-H., Liu, Y., Wang, J., Xian, P., Zhang, Y., Yang, Y., Zhang, H., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101732 · Cited by 21
Lamantia, V., Bissonnette, S., Beaudry, M., Cyr, Y., Rosiers, C. D., Baass, A. W., & Faraj, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-73672-6 · Cited by 24
Sepsis and high-density lipoproteins: Pathophysiology and potential new therapeutic targets
Parolini, C. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167761 · Cited by 24
Blood-Related Toxicity after Traumatic Brain Injury: Potential Targets for Neuroprotection
Robicsek, S. A., Bhattacharya, A., Rabai, F., Shukla, K., & Doré, S. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01766-8 · Cited by 22
Pathways linking Alzheimer’s disease risk genes expressed highly in microglia
Hodges, A. K., Piers, T. M., Collier, D., Cousins, O., & Pocock, J. M. (2021) · Neuroimmunology and Neuroinflammation · doi:10.20517/2347-8659.2020.60 · Cited by 21
Metadata
- Authors
- Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., Rayner, K. J., Boyer, L., Zhong, R., Frazier, W. A., Lacy-Hulbert, A., Khoury, J. E., Golenbock, D. T., & Moore, K. J.
- Affiliations
- Harvard University (US)
- University of Massachusetts Chan Medical School (US)
- Washington University in St. Louis (US)
- Corresponding author
- Moore, Kathryn J
- ORCID
- Venue
- Nature Immunology
- Published
- 2009-12-27
- Volume
- 11
- Issue
- 2
- Pages
- 155-161
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC2809046
- OpenAlex
- W2045772297
- Cited by
- 1,513
- References
- 42
- Citations by year
- 2026: 53 · 2025: 69 · 2024: 107 · 2023: 74 · 2022: 108 · 2021: 96 · 2020: 102 · 2019: 97 · 2018: 99 · 2017: 94 · 2016: 98 · 2015: 108 · 2014: 81 · 2013: 92 · 2012: 104
- FWCI
- 33.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Wellcome Trust (068089)
- National Institute on Aging (R01AG20255, R01AG020255, R01AG032349)
- National Institute of Allergy and Infectious Diseases (R01AI079198)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK043351)
- National Institute of Neurological Disorders and Stroke (R01NS059005)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- CD36, TLR4, TLR6, sterile inflammation, oxidized LDL, amyloid-beta, atherosclerosis, Alzheimer's disease, innate immune activation
- MeSH terms
- Animals, Cell Line, Humans, Inflammation, Lipoproteins, LDL, Mice, Inbred C57BL, Blotting, Western, Signal Transduction, Gene Expression, Amyloid beta-Peptides, Microglia, Mice, Knockout, Chemokines, CD36 Antigens, Reverse Transcriptase Polymerase Chain Reaction, Immunoprecipitation, Atherosclerosis, Toll-Like Receptor 4, Toll-Like Receptor 6, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review